Excitingly, MEK inhibitors were effective in treating some, if not all, of the other RASopathy manifestations, in the Ptpn11D61G and Raf1L613V knock-in mouse models of NS (Lee et al., 2014; Wu et al., 2011). Here, MAP2K7 is linked to RASopathy.